folic acid has been researched along with T-Cell Lymphoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Björklund, M; Caldez, MJ; Kaldis, P; Zhao, LN; Zheng, J | 1 |
| Choi, JS; Kim, HJ; Kim, HN; Kim, YK; Lee, IK; Lee, JJ; Park, KS; Shin, MG; Shin, MH; Tran, HT; Yang, DH | 1 |
| Berthelot, CN; Duvic, M; Jones, D; Leitenberger, JJ; McLaughlin, P; Polder, KD; Pro, B | 1 |
1 review(s) available for folic acid and T-Cell Lymphoma
| Article | Year |
|---|---|
Therapeutic targeting of the mitochondrial one-carbon pathway: perspectives, pitfalls, and potential.
Topics: Carbon; Folic Acid; Humans; Lymphoma, T-Cell; Metabolic Networks and Pathways; Mitochondria; Neoplasms | 2021 |
2 other study(ies) available for folic acid and T-Cell Lymphoma
| Article | Year |
|---|---|
Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Case-Control Studies; Female; Ferredoxin-NADP Reductase; Folic Acid; Gene Frequency; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Odds Ratio; Polymorphism, Genetic; Risk; Thymidylate Synthase | 2008 |
CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate.
Topics: Aged; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; CD4 Antigens; CD56 Antigen; Cyclophosphamide; Dendritic Cells; Doxorubicin; Drug Therapy, Combination; Female; Folic Acid; Humans; Killer Cells, Natural; Lymphoma, T-Cell; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prednisone; Skin Neoplasms; Treatment Outcome; Vincristine; Vitamin B 12 | 2008 |